Literature DB >> 8411026

Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment.

S Adam1, S Wiggins, P Whyte, M Bloch, M H Shokeir, H Soltan, W Meschino, A Summers, O Suchowersky, J P Welch.   

Abstract

Adult predictive and prenatal testing programmes for Huntington's disease (HD) in Canada have been available since 1986. However, the demand for prenatal testing and the reasons why some people choose not to have the prenatal test for this late onset disorder have not been well documented. In addition, the knowledge and attitudes of adult predictive testing candidates and their partners about prenatal testing are not well known nor are the psychological effects of prenatal testing well understood. As of September 1991, 425 subjects had entered the Canadian Collaborative Study of Predictive Testing and, of these, 47 subjects or their partners had become pregnant. Of this group, 14 (30%) couples requested prenatal testing, 24 (51%) couples did not want prenatal testing, and nine (19%) at risk subjects had already received a decreased risk through adult predictive testing and, therefore, were not eligible for the prenatal test. Of the 14 couples who initially requested prenatal testing, seven withdrew. Thus, demand for the prenatal test by eligible candidates was 7/38 or 18%, which is much lower than the 32 to 65% expected based on early survey data. The most frequently cited reason for declining prenatal testing was the hope that a cure would be found in time for their children. While the majority of adult predictive testing candidates (71%) in our study had accurate information about definitive prenatal testing, many (63%) did not have a correct understanding of exclusion prenatal testing. Although no serious adverse events such as suicide planning or admission to psychiatric hospital have occurred, a particular need for careful counselling was identified for those at risk candidates and their partners who have one prenatal test and feel compelled to use the test again in future pregnancies. Even though prenatal testing for HD is not requested as often originally expected, it still remains a desired option for some at risk persons and their partners.

Entities:  

Mesh:

Year:  1993        PMID: 8411026      PMCID: PMC1016453          DOI: 10.1136/jmg.30.7.549

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  11 in total

1.  Prenatal diagnosis of a double bisatellited marker with an unusual copy number ratio.

Authors:  J J Waters; M E Ferguson-Smith; N Carter; J L Alexander; S V Hodgson
Journal:  Prenat Diagn       Date:  1990-10       Impact factor: 3.050

2.  Chromosomal in situ suppression hybridization of human gonosomes and autosomes and its use in clinical cytogenetics.

Authors:  A Jauch; C Daumer; P Lichter; J Murken; T Schroeder-Kurth; T Cremer
Journal:  Hum Genet       Date:  1990-07       Impact factor: 4.132

3.  Chromosome in situ suppression hybridisation in clinical cytogenetics.

Authors:  M A Hulten; C P Gould; A S Goldman; J J Waters
Journal:  J Med Genet       Date:  1991-09       Impact factor: 6.318

4.  Study of X chromosome abnormality in XX males using bivariate flow karyotype analysis and flow sorted dot blots.

Authors:  N P Carter; M E Ferguson-Smith; N A Affara; H Briggs; M A Ferguson-Smith
Journal:  Cytometry       Date:  1990

5.  Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries.

Authors:  P Lichter; T Cremer; J Borden; L Manuelidis; D C Ward
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

6.  Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes.

Authors:  T Cremer; P Lichter; J Borden; D C Ward; L Manuelidis
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

7.  Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4.

Authors:  D Pinkel; J Landegent; C Collins; J Fuscoe; R Segraves; J Lucas; J Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

8.  Rapid detection of human chromosome 21 aberrations by in situ hybridization.

Authors:  P Lichter; T Cremer; C J Tang; P C Watkins; L Manuelidis; D C Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  Assignment of aberration breakpoints in banded chromosomes.

Authors:  J R Savage
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

10.  Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes.

Authors:  H Telenius; A H Pelmear; A Tunnacliffe; N P Carter; A Behmel; M A Ferguson-Smith; M Nordenskjöld; R Pfragner; B A Ponder
Journal:  Genes Chromosomes Cancer       Date:  1992-04       Impact factor: 5.006

View more
  14 in total

1.  Preimplantation genetic diagnosis (PGD) for Huntington's disease: the experience of three European centres.

Authors:  Maartje C Van Rij; Marjan De Rademaeker; Céline Moutou; Jos C F M Dreesen; Martine De Rycke; Inge Liebaers; Joep P M Geraedts; Christine E M De Die-Smulders; Stéphane Viville
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

Review 2.  Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review.

Authors:  R Timman; T Stijnen; A Tibben
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

Review 3.  A case-note review of continued pregnancies found to be at a high risk of Huntington's disease: considerations for clinical practice.

Authors:  Felicity Wadrup; Simon Holden; Rhona MacLeod; Zosia Miedzybrodzka; Andrea H Németh; Shan Owens; Sara Pasalodos; Oliver Quarrell; Angus J Clarke
Journal:  Eur J Hum Genet       Date:  2019-03-19       Impact factor: 4.246

4.  The prenatal exclusion test for Huntington's disease: experience in the west of Scotland, 1986-1993.

Authors:  J L Tolmie; H R Davidson; H M May; K McIntosh; J S Paterson; B Smith
Journal:  J Med Genet       Date:  1995-02       Impact factor: 6.318

5.  Prenatal testing in Huntington disease: after the test, choices recommence.

Authors:  Hanane Bouchghoul; Stéphane-Françoise Clément; Danièle Vauthier; Cécile Cazeneuve; Sandrine Noel; Marc Dommergues; Delphine Héron; Jacky Nizard; Marcela Gargiulo; Alexandra Durr
Journal:  Eur J Hum Genet       Date:  2016-06-15       Impact factor: 4.246

6.  Attitudes towards bipolar disorder and predictive genetic testing among patients and providers.

Authors:  L B Smith; B Sapers; V I Reus; N B Freimer
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

7.  Attitudes to predictive DNA testing in familial adenomatous polyposis.

Authors:  S Whitelaw; J M Northover; S V Hodgson
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

8.  Couples at risk for spinocerebellar ataxia type 2: the Cuban prenatal diagnosis experience.

Authors:  Tania Cruz-Mariño; Luis Velázquez-Pérez; Yanetza González-Zaldivar; Raúl Aguilera-Rodríguez; Miguel Velázquez-Santos; Yaimé Vázquez-Mojena; Annelié Estupiñán-Rodríguez; Rubén Reynaldo-Armiñán; Luis Enrique Almaguer-Mederos; José Miguel Laffita-Mesa; Victor Tamayo-Chiang; Milena Paneque
Journal:  J Community Genet       Date:  2013-05-15

Review 9.  Presymptomatic testing for genetic diseases of later life. Pharmacoepidemiological considerations.

Authors:  B J Rossiter; C T Caskey
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

10.  Attitude towards pre-implantation genetic diagnosis for hereditary cancer.

Authors:  Chantal Lammens; Eveline Bleiker; Neil Aaronson; Annette Vriends; Margreet Ausems; Maaike Jansweijer; Anja Wagner; Rolf Sijmons; Ans van den Ouweland; Rob van der Luijt; Liesbeth Spruijt; Encarna Gómez García; Mariëlle Ruijs; Senno Verhoef
Journal:  Fam Cancer       Date:  2009-07-30       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.